Inhibikase Therapeutics, Inc.

NASDAQ:IKT

Biotechnology

Healthcare
$1.38 +3.57%

+$0.06 today

Market cap
$193.57M
Beta
0.97
P/E (TTM)
-3.4
EPS (TTM)
-$0.52
52W Low $1.33High $2.26

Volume 0.43M

Average 1.03M

News

For Inhibikase Therapeutics, Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.

No stories for IKT yet. A story appears once at least three publishers cover the same event.